Medications

Scientists raise concern over hydroxychloroquine study

Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs ...

Diseases, Conditions, Syndromes

WHO suspends hydroxychloroquine trial as COVID-19 treatment

The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.

Medications

Epilepsy drug inhibits brain tumor development

Medication prescribed for a certain type of epilepsy may offer a new method for treating malignant infantile brain tumors. A specific mTOR inhibitor has the ability to cross the blood-brain barrier to both reach and attack ...

Medications

Turmeric may be as good for treating indigestion as omeprazole

A natural compound found in the culinary spice turmeric may be as effective as omeprazole—a drug used to curb excess stomach acid—for treating indigestion symptoms, suggests the first study of its kind, published online ...

Diseases, Conditions, Syndromes

More deaths, no benefit from malaria drug in VA virus study (Update)

A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine ...

Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.

page 1 from 24